Botensilimab Plus Balstilimab Improves Outcomes in Recurrent Platinum-Resistant/-Refractory Ovarian Cancer

In patients with recurrent platinum-resistant/-refractory ovarian cancer, treatment with botensilimab plus ...

MAY 10, 2023